Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the top gene therapy stocks to buy according to hedge funds. On February 25, ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Frailty can typically only be lessened through lifestyle changes, but a stem cell therapy seems to target the underlying ...

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

O3, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets ...

Recent medical advances in gene and cell therapies have renewed hope for some patients with aggressive blood cancers.

Hospitals and cancer centers that are launching cell and gene therapy programs need more than scientific breakthroughs to succeed. Delivering these therapies safely and efficientl ...

With 300 million people living with rare diseases, experts say new gene and cell therapies are giving families in Wisconsin hope for lasting treatment options.

Researchers at the Sanford Stem Cell Institute have taken the fight against rare diseases to the lab, to patients’ bedsides ...

Metabolon helped Kite study the link between metabolic signatures and the severity of neurological evens in samples from ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

Associate Professor in Microvascular Medicine, Rebecca Foster, explores therapeutic approaches to improve kidney health for ...